EPIRUS Biopharmaceuticals, Inc. Interest Expense
EPIRUS Biopharmaceuticals, Inc. reported Interest Expense of $86.00 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2014-08-11
- EPIRUS Biopharmaceuticals, Inc. interest expense for the quarter ending 2014-06-30 was $1.00K, a 99.75% decline year-over-year.
- EPIRUS Biopharmaceuticals, Inc. interest expense for the quarter ending 2014-03-31 was $85.00K, a 80.68% decline year-over-year.
- EPIRUS Biopharmaceuticals, Inc. interest expense for the quarter ending 2013-12-31 was $292.00K, a 40.04% decline year-over-year.
- EPIRUS Biopharmaceuticals, Inc. interest expense for the quarter ending 2013-09-30 was $342.00K, a 35.71% decline year-over-year.
- EPIRUS Biopharmaceuticals, Inc. interest expense for fiscal 2013 was $1.47M, a 32.49% decline from fiscal 2012.
- EPIRUS Biopharmaceuticals, Inc. interest expense for fiscal 2012 was $2.17M, a 122.64% increase from fiscal 2011.
- EPIRUS Biopharmaceuticals, Inc. interest expense for fiscal 2011 was $976.00K, a 8033.33% increase from fiscal 2010.
- EPIRUS Biopharmaceuticals, Inc. interest expense for fiscal 2010 was $12.00K, a 57.14% decline from fiscal 2009.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2014-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $86.00K 10-Q · filed 2014-08-11 | $378.00K derived: sum of 3 quarters · filed 2014-08-11 | $720.00K derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | $85.00K 10-Q · filed 2014-05-09 | $377.00K derived: sum of 2 quarters · filed 2014-05-09 | $719.00K derived: sum of 3 quarters · filed 2014-05-09 | $1.11M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-12-31 | $292.00K 10-K · filed 2014-03-14 | $634.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.03M derived: sum of 3 quarters · filed 2014-08-11 | $1.47M 10-K · filed 2014-03-14 |
| 2013-09-30 | $342.00K 10-K · filed 2014-03-14 | $735.00K derived: sum of 2 quarters · filed 2014-08-11 | $1.18M 10-Q · filed 2013-11-04 | $1.66M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-06-30 | $393.00K 10-Q · filed 2014-08-11 | $833.00K 10-Q · filed 2014-08-11 | $1.32M derived: sum of 3 quarters · filed 2014-08-11 | $1.85M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $440.00K 10-Q · filed 2014-05-09 | $927.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.46M derived: sum of 3 quarters · filed 2014-03-14 | $2.02M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-12-31 | $487.00K 10-K · filed 2014-03-14 | $1.02M derived: sum of 2 quarters · filed 2014-03-14 | $1.58M derived: sum of 3 quarters · filed 2014-03-14 | $2.17M 10-K · filed 2014-03-14 |
| 2012-09-30 | $532.00K 10-K · filed 2014-03-14 | $1.09M derived: sum of 2 quarters · filed 2014-03-14 | $1.69M 10-Q · filed 2013-11-04 | $2.08M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $563.00K 10-K · filed 2014-03-14 | $1.15M 10-Q · filed 2013-08-05 | $1.55M derived: sum of 3 quarters · filed 2014-03-14 | $1.91M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $591.00K 10-K · filed 2014-03-14 | $988.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.35M derived: sum of 3 quarters · filed 2014-03-14 | $1.46M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $397.00K 10-K · filed 2013-03-07 | $755.00K derived: sum of 2 quarters · filed 2013-03-07 | $871.00K derived: sum of 3 quarters · filed 2013-03-07 | $976.00K 10-K · filed 2014-03-14 |
| 2011-09-30 | $358.00K 10-K · filed 2013-03-07 | $474.00K derived: sum of 2 quarters · filed 2013-03-07 | $579.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $116.00K 10-K · filed 2013-03-07 | $221.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $105.00K 10-K · filed 2013-03-07 | |||
| 2010-12-31 | $12.00K 10-K · filed 2013-03-07 | |||
| 2009-12-31 | $28.00K 10-K · filed 2012-03-09 |